Total Payments
$11,989
2024 Payments
$1,872
Companies
55
Transactions
613
Medicare Patients
17,372
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$11,575 (96.5%)
Education$413.86 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,575 | 607 | 96.5% |
| Education | $413.86 | 6 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,042 | 114 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $2,021 | 105 | $0 (2024) |
| Astellas Pharma US Inc | $956.77 | 42 | $0 (2022) |
| Myriad Genetic Laboratories, Inc. | $870.76 | 36 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $676.39 | 33 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $383.31 | 17 | $0 (2024) |
| ABBVIE INC. | $364.18 | 22 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $362.02 | 25 | $0 (2023) |
| PFIZER INC. | $315.77 | 28 | $0 (2024) |
| Blue Earth Diagnostics Limited | $303.32 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,872 | 84 | Dendreon Pharmaceuticals LLC ($589.23) |
| 2023 | $2,064 | 89 | Myriad Genetic Laboratories, Inc. ($441.71) |
| 2022 | $1,942 | 97 | Janssen Biotech, Inc. ($354.30) |
| 2021 | $1,829 | 105 | Dendreon Pharmaceuticals LLC ($243.33) |
| 2020 | $689.89 | 40 | Astellas Pharma US Inc ($162.79) |
| 2019 | $1,155 | 56 | Astellas Pharma US Inc ($355.54) |
| 2018 | $1,092 | 76 | Dendreon Pharmaceuticals LLC ($296.14) |
| 2017 | $1,344 | 66 | Janssen Biotech, Inc. ($274.58) |
All Payment Transactions
613 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/20/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diagnostic Imaging | ||||||
| 11/04/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/08/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Oncology | ||||||
| 10/01/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Immunotherapy | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: Oncology | ||||||
| 09/24/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/10/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: Oncology | ||||||
| 08/22/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $129.30 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,891 | 9,213 | $654,826 | $203,322 |
| 2022 | 40 | 4,263 | 9,577 | $741,270 | $242,062 |
| 2021 | 43 | 4,955 | 13,742 | $957,140 | $367,528 |
| 2020 | 41 | 4,263 | 9,153 | $601,200 | $203,345 |
Total Patients
17,372
Total Services
41,685
Medicare Billing
$1.0M
Procedure Codes
154
All Medicare Procedures & Services
154 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 433 | 579 | $120,948 | $47,830 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 461 | 653 | $81,515 | $39,545 | 48.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 121 | 141 | $67,539 | $24,266 | 35.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 24 | 156 | $98,904 | $21,040 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 146 | 146 | $45,108 | $15,245 | 33.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 382 | 501 | $33,933 | $9,001 | 26.5% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 35 | 36 | $30,900 | $6,998 | 22.6% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 18 | 19 | $23,370 | $6,168 | 26.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 720 | 1,155 | $21,854 | $5,851 | 26.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 37 | 38 | $10,602 | $3,869 | 36.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $6,583 | $2,800 | 42.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 67 | 108 | $10,304 | $2,731 | 26.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 256 | 341 | $11,875 | $2,497 | 21.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $4,250 | $2,353 | 55.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 451 | 677 | $8,084 | $2,101 | 26.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 35 | 35 | $7,665 | $1,866 | 24.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 25 | 60 | $5,280 | $1,350 | 25.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 13 | 13 | $11,200 | $1,297 | 11.6% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 14 | 15 | $3,750 | $1,212 | 32.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 384 | 522 | $4,156 | $1,147 | 27.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 14 | 20 | $3,700 | $941.40 | 25.4% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 44 | 55 | $2,805 | $820.08 | 29.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 15 | $1,125 | $576.14 | 51.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 29 | $1,015 | $513.30 | 50.6% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 38 | 3,751 | $35,030 | $422.17 | 1.2% |
About Dr. Brian Bennett, M.D
Dr. Brian Bennett, M.D is a Urology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891766077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Bennett, M.D has received a total of $11,989 in payments from pharmaceutical and medical device companies, with $1,872 received in 2024. These payments were reported across 613 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($11,575).
As a Medicare-enrolled provider, Bennett has provided services to 17,372 Medicare beneficiaries, totaling 41,685 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 154 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Raleigh, NC
- Active Since 01/27/2006
- Last Updated 01/22/2014
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1891766077
Products in Payments
- PROVENGE (Drug) $2,070
- ERLEADA (Drug) $1,352
- GEMTESA (Drug) $815.70
- ZYTIGA (Drug) $523.42
- XTANDI (Drug) $474.88
- PROLARIS (Device) $470.55
- XIAFLEX (Biological) $388.08
- Xofigo (Drug) $320.38
- BOTOX (Biological) $301.65
- MYRBETRIQ (Drug) $254.12
- KEYTRUDA (Biological) $253.79
- Axumin (Drug) $246.18
- JELMYTO (Drug) $241.52
- CAMCEVI (Drug) $238.32
- Natesto (Drug) $208.53
- ORGOVYX (Drug) $204.29
- XYOSTED (Drug) $186.70
- Erleada (Drug) $183.13
- iTIND System (Device) $178.77
- Myrbetriq (Drug) $151.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Raleigh
Dr. Mark Jalkut, Md, MD
Urology — Payments: $124,401
Urology $124,401
Scott Baker, Md, MD
Urology — Payments: $17,878
Urology $17,878
Dr. Andrew Chang, Md, MD
Urology — Payments: $14,872
Urology $14,872
Dr. Joseph Neighbors, M.d, M.D
Urology — Payments: $12,226
Urology $12,226
Merry Ma
Urology — Payments: $12,107
Urology $12,107
Dr. Stephen Shaban, Md, MD
Urology — Payments: $11,877
Urology $11,877